| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 13Q3A43E0S |
| InChI Key | GUBGYTABKSRVRQ-DCSYEGIMSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H22O11 |
| Molecular Weight | 342.3 |
| AlogP | -5.4 |
| Hydrogen Bond Acceptor | 11.0 |
| Hydrogen Bond Donor | 8.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 189.53 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 23.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Other cytosolic protein
|
- | - | 37920-62000 | - | 67-75 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Fractures, Bone | 3 | D050723 | ClinicalTrials |
| Vitamin D Deficiency | 3 | D014808 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 3 | D065626 | ClinicalTrials |
| Diarrhea | 3 | D003967 | ClinicalTrials |
| Asthma | 3 | D001249 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
| Raynaud Disease | 3 | D011928 | ClinicalTrials |
| Tuberculosis | 3 | D014376 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
| Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
| Paramyxoviridae Infections | 2 | D018184 | ClinicalTrials |
| Urinary Bladder, Overactive | 2 | D053201 | ClinicalTrials |
| Enuresis | 2 | D004775 | ClinicalTrials |
| Migraine Disorders | 2 | D008881 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
| Acute Lung Injury | 2 | D055371 | ClinicalTrials |
| Bronchiolitis Obliterans | 2 | D001989 | ClinicalTrials |
| Respiratory Distress Syndrome | 2 | D012128 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Tobacco Use Disorder | 2 | D014029 | ClinicalTrials |
| Gastroesophageal Reflux | 2 | D005764 | ClinicalTrials |
| Pain | 2 | D010146 | ClinicalTrials |
| Periodontitis | 0 | D010518 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 36218 |
| ChEMBL | CHEMBL417016 |
| EPA CompTox | DTXSID2023193 |
| FDA SRS | 13Q3A43E0S |
| Human Metabolome Database | HMDB0041627 |
| KEGG | C01970 |
| SureChEMBL | SCHEMBL782 |
| ZINC | ZINC000004095761 |